Updated: FDA’s safety review on CAR-Ts culminates in new boxed warnings of secondary cancer

Updated: FDA’s safety review on CAR-Ts culminates in new boxed warnings of secondary cancer

Upworthy

Published

The FDA has told No­var­tis, Gilead, Bris­tol My­ers Squibb and John­son & John­son to add boxed warn­ings on the la­bels of six CAR-T ther­a­pies not­ing the risks of sec­ondary can­cer. The agency caused a stir in the CAR-T space when it re­vealed the safe­ty re­view in No­vem­ber, which came as…

#fda #novartis #gilead #bristol #squibb #johnsonjohnson #scientists #clinicians #unlock

Full Article